Coastline Trust Co trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD – Get Rating) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,215 shares of the medical instruments supplier’s stock after selling 20 shares during the period. Coastline Trust Co’s holdings in Mettler-Toledo International were worth $2,062,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of the business. CVA Family Office LLC acquired a new position in shares of Mettler-Toledo International during the fourth quarter worth about $25,000. Eagle Bay Advisors LLC boosted its position in shares of Mettler-Toledo International by 44.4% during the third quarter. Eagle Bay Advisors LLC now owns 26 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 8 shares during the period. Amplius Wealth Advisors LLC acquired a new position in shares of Mettler-Toledo International during the fourth quarter worth about $39,000. Moors & Cabot Inc. acquired a new position in shares of Mettler-Toledo International during the third quarter worth about $51,000. Finally, Sageworth Trust Co of South Dakota acquired a new position in shares of Mettler-Toledo International during the fourth quarter worth about $56,000. 93.88% of the stock is owned by hedge funds and other institutional investors.
MTD has been the subject of several recent research reports. Robert W. Baird upped their price objective on Mettler-Toledo International from $1,531.00 to $1,595.00 in a research report on Friday, February 11th. Wells Fargo & Company upgraded Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and dropped their target price for the stock from $1,600.00 to $1,410.00 in a report on Monday, April 25th. StockNews.com started coverage on Mettler-Toledo International in a report on Thursday, March 31st. They set a “buy” rating on the stock. Finally, The Goldman Sachs Group lowered Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 price objective on the stock. in a research note on Thursday, March 10th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $1,449.25.
Shares of NYSE MTD traded up $43.17 during trading hours on Tuesday, reaching $1,239.24. 5,809 shares of the stock were exchanged, compared to its average volume of 129,593. The firm has a market capitalization of $28.18 billion, a price-to-earnings ratio of 35.13, a P/E/G ratio of 1.80 and a beta of 1.07. The company has a debt-to-equity ratio of 9.22, a quick ratio of 0.75 and a current ratio of 1.11. Mettler-Toledo International Inc. has a 52 week low of $1,188.56 and a 52 week high of $1,714.75. The stock’s fifty day simple moving average is $1,343.70 and its 200 day simple moving average is $1,457.25.
Mettler-Toledo International (NYSE:MTD – Get Rating) last issued its quarterly earnings results on Thursday, May 5th. The medical instruments supplier reported $7.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.28 by $0.59. The business had revenue of $897.80 million for the quarter, compared to the consensus estimate of $868.08 million. Mettler-Toledo International had a return on equity of 471.45% and a net margin of 20.82%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.56 earnings per share. Research analysts predict that Mettler-Toledo International Inc. will post 38.38 EPS for the current fiscal year.
Mettler-Toledo International Profile (Get Rating)
Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
- Get a free copy of the StockNews.com research report on Mettler-Toledo International (MTD)
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Intuitive Surgical is an Intuitive Buy
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.